![]() |
| Drug prevents bone loss in prostate cancer: Amgen (Reu |
|
RSS FEED
|
Reuters - In a study, Amgen Inc's experimental drug denosumab reduced the risk of osteoporosis and fracture in men being treated with prostate cancer medicines that can cause bone loss, the company said on Monday. Read more... |
||||||||||||
|
|
|||||||||||||
| Drug prevents bone loss in prostate cancer: Amgen (Reu |
|
||
|
Site Map
|
Sitemap |

